Karyopharm Therapeutics Inc (KPTI)
1.06
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
1.05
-0.01
(-0.94%)
After-Hours: 20:00
Karyopharm Therapeutics Max Drawdown (5Y): 97.56% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 97.56% |
February 29, 2024 | 97.56% |
January 31, 2024 | 97.56% |
December 31, 2023 | 97.56% |
November 30, 2023 | 97.56% |
October 31, 2023 | 97.11% |
September 30, 2023 | 95.89% |
August 31, 2023 | 95.38% |
July 31, 2023 | 94.62% |
June 30, 2023 | 93.54% |
May 31, 2023 | 91.99% |
April 30, 2023 | 91.26% |
March 31, 2023 | 91.26% |
February 28, 2023 | 91.26% |
January 31, 2023 | 91.26% |
December 31, 2022 | 91.26% |
November 30, 2022 | 91.26% |
October 31, 2022 | 91.26% |
September 30, 2022 | 91.26% |
August 31, 2022 | 91.26% |
July 31, 2022 | 91.26% |
June 30, 2022 | 91.26% |
May 31, 2022 | 91.26% |
April 30, 2022 | 91.26% |
March 31, 2022 | 91.26% |
Date | Value |
---|---|
February 28, 2022 | 91.26% |
January 31, 2022 | 91.26% |
December 31, 2021 | 91.26% |
November 30, 2021 | 91.26% |
October 31, 2021 | 91.26% |
September 30, 2021 | 91.26% |
August 31, 2021 | 91.26% |
July 31, 2021 | 91.26% |
June 30, 2021 | 91.26% |
May 31, 2021 | 91.26% |
April 30, 2021 | 91.26% |
March 31, 2021 | 91.26% |
February 28, 2021 | 91.26% |
January 31, 2021 | 91.26% |
December 31, 2020 | 91.26% |
November 30, 2020 | 91.26% |
October 31, 2020 | 91.26% |
September 30, 2020 | 91.26% |
August 31, 2020 | 91.26% |
July 31, 2020 | 91.26% |
June 30, 2020 | 91.26% |
May 31, 2020 | 91.26% |
April 30, 2020 | 91.26% |
March 31, 2020 | 91.26% |
February 29, 2020 | 91.26% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
91.26%
Minimum
Apr 2019
97.56%
Maximum
Nov 2023
92.13%
Average
91.26%
Median
Apr 2019
Max Drawdown (5Y) Benchmarks
Geron Corp | 86.09% |
Arbutus Biopharma Corp | 96.69% |
Verastem Inc | 97.04% |
Actinium Pharmaceuticals Inc | 97.29% |
Chimerix Inc | 97.79% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -26.05 |
Beta (5Y) | 0.0269 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 80.39% |
Historical Sharpe Ratio (5Y) | -0.3197 |
Historical Sortino (5Y) | -0.5744 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.03% |